603590 Beijing Konruns Pharmaceutical
- 23.68
- +0.28+1.20%
Beijing Konruns Pharmaceutical News
Kangchen Pharmaceutical: Kangchen Pharmaceutical\'s announcement on changing the company\'s registered capital and amending the “Articles of Association”
Kangchen Pharmaceutical: Notice on Cancelling the Company\'s Repurchase of Shares in Special Securities Accounts
Kangchen Pharmaceutical: Kangchen Pharmaceutical\'s Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Kangchen Pharmaceutical: Announcement on the repurchase and cancellation of some restricted stocks that have been granted incentives but sales restrictions have not yet been lifted, and the adjustment of repurchase prices
Kangchen Pharmaceutical\'s Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Articles of Association of Beijing Kangchen Pharmaceutical Co., Ltd. (Revised in September 2024)
Kangchen Pharmaceutical\'s announcement on changing the company\'s registered capital and revising the “Articles of Association”
Kangchen Pharmaceutical\'s announcement on the appointment of Chief Financial Officer
Beijing Kangchen Pharmaceutical Co., Ltd. Accountant Service Selection and Employment System
Announcement of Resignation of Senior Management Personnel from Beijing Konruns Pharmaceutical
Announcement from Beijing Konruns Pharmaceutical on traditional Chinese medicine innovative drug ZY5301 clinical research results being featured in the sub-journal of JAMA.
Announcement on the Change of Continuous Supervision and Sponsorship Representative of Beijing Konruns Pharmaceutical
Announcement on the signing of house rental contract and related trade of Beijing Konruns Pharmaceutical
Kangchen Pharmaceutical's announcement on being certified as the 8th batch of national manufacturing individual champion enterprises
Announcement of Resolutions of Kangchen Pharmaceutical's 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Guofeng Law Firm on the 2023 Annual General Meeting of Shareholders of Beijing Kangchen Pharmaceutical Co., Ltd.
Kangchen Pharmaceutical's 2023 Annual General Meeting of Shareholders Meeting Materials
Kangchen Pharmaceutical's announcement on preparation for asset impairment in 2023
Kangchen Pharmaceutical's announcement on the completion of the 2023 annual performance commitment for Beijing Kangchen Biotechnology Co., Ltd.'s secret interest rate cover business
Kangchen Pharmaceutical's Notice on Convening the 2023 Annual General Meeting of Shareholders
Analysis
Price Target
No Data
No Data